Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

NASDAQ:HOWL

Overview | Financials
Company Name Werewolf Therapeutics, Inc.
Symbol HOWL
Currency USD
Price 2.02
Market Cap 88,278,444
Dividend Yield 0%
52-week-range 1.574 - 8.194
Industry Biotechnology
Sector Healthcare
CEO Dr. Daniel J. Hicklin Ph.D.
Website https://werewolftx.com

An error occurred while fetching data.

About Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates

Related Stocks

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

18.63 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

5.75 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

13.23 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

8.42 USD

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.1 USD

Financials

Numbers are in millions USD

Numbers are in millions USD